Choropleth — Participants Randomised by Country, Phase III Trial
Randomisations by country for a fictional global phase III cardiovascular outcomes trial at its enrolment cut-off: 2,463 participants from 29 recruiting countries, led by the USA (412), China (188) and Germany (167); Ukraine and the Philippines are shown at zero because their sites were activated and then closed before randomising. The map a data monitoring committee looks at for regional imbalance. Illustrative values.
Make it your own.
title "Participants randomised by country — 2,463 total (illustrative)"
atlas world
scale "#f5f3ff" "#5b21b6"
legend "Participants randomised"
# Countries with sites only. UKR and PHL: sites activated, none randomised (shown at 0).
USA 412
CAN 96
MEX 58
BRA 131
ARG 74
COL 22
PER 18
CHL 27
GBR 148
FRA 121
DEU 167
ESP 139
ITA 104
POL 112
NLD 46
BEL 39
SWE 31
NOR 12
FIN 15
UKR 0
TUR 63
GRC 34
ZAF 41
CHN 188
JPN 97
KOR 84
IND 76
AUS 69
NZL 14
THA 25
PHL 0